Journal
DRUG DELIVERY
Volume 28, Issue 1, Pages 594-606Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2021.1898703
Keywords
Drug delivery; melanoma; combination therapy; nanoparticles; metformin; doxorubicin; PANoptosis
Categories
Funding
- Natural Science Foundation of China [31800992, 92057112, 31771298, 81800512]
- Natural Science Foundation of Jiangsu Province [BK20180554, BK20180577]
- Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMZZRC202005]
- Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD]
Ask authors/readers for more resources
The study successfully developed a nanoparticle system based on biomaterials for co-delivery of MET and DOX into melanoma tumors, resulting in the inhibition of melanoma progression.
Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy. Although combined therapies of metformin (MET) and doxorubicin (DOX) are effective in treating a variety of cancers, including breast cancer, their different physicochemical properties and administration routines reduce the effective co-accumulation of both drugs in tumors. Nanoparticles (NPs) have been demonstrated to potentially improve drug delivery efficiency in cancer therapy of, for example, liver and lung cancers. Hence, in this study, we prepared pH-sensitive, biocompatible, tumor-targeting NPs based on the conjugation of biomaterials, including sodium alginate, cholesterol, and folic acid (FCA). As expected, since cholesterol and folic acid are two essentials, but insufficient, substrates for melanoma growth, we observed that the FCA NPs specifically and highly effectively accumulated in xenograft melanoma tumors. Taking advantage of the FCA NP system, we successfully co-delivered a combination of MET and DOX into melanoma tumors to trigger pyroptosis, apoptosis, and necroptosis (PANoptosis) of the melanoma cells, thus blocking melanoma progression. Combined, the establishment of such an FCA NP system provides a promising vector for effective drug delivery into melanoma and increases the possibility and efficiency of drug combinations for cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available